ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

Täydet tiedot

Bibliografiset tiedot
Päätekijä: R.T. Saygitov
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: "Paediatrician" Publishers LLC 2008-08-01
Sarja:Вопросы современной педиатрии
Linkit:https://vsp.spr-journal.ru/jour/article/view/1441

Samankaltaisia teoksia